XML 18 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
Restatement of Financial Statements
9 Months Ended
Mar. 31, 2018
Accounting Changes and Error Corrections [Abstract]  
Restatement of Financial Statements
2. Restatement of Financial Statements

 

On August 2, 2018, the Company mistakenly filed a wrong version of Form 10-Q for the period ended March 31, 2018, the Consolidated Statement of Operations for the three and nine months ended March 31, 2018 and Statement of Cash Flows for the nine-month period ending on March 31, 2018 was misstated. Below is a summary of the adjustments/restatement of the mistakenly filed 10-Q.

 

   For the Three Months Ended March 31, 2018  For the Nine Months Ended March 31, 2018
   (Original)  (Adjustment)  (Restated)  (Original)  (Adjustment)  (Restated)
                   
Revenues, net  $2,965,404   $(2,115,968)  $849,436   $5,081,372   $(2,115,968)  $2,965,404 
                               
Cost of goods sold:   2,107,834    (1,512,946)   594,888    3,618,033    (1,510,199)   2,107,834 
                               
Total cost of goods sold   2,107,834    (1,512,946)   594,888    3,618,033    (1,510,199)   2,107,834 
                               
Gross profit   857,570    (603,021)   254,549    1,463,339    (605,769)   857,570 
                               
Operating expenses:                              
Selling, general and administrative expenses   2,849,789    (2,052,593)   797,196    4,901,953    (2,052,164)   2,849,789 
                               
Total operating expenses   2,849,789    (2,052,593)   797,196    4,901,953    (2,052,164)   2,849,789 
                               
Loss from operations   (1,992,220)   1,449,573    (542,647)   (3,438,615)   1,446,396    (1,992,219)
                               
Non-operating income (expense):                              
Other income   14,206    (14,206)   —      29,281    (15,075)   14,206 
Interest expense   (303,484)   206,377    (97,107)   (509,813)   206,329    (303,484)
Change in fair value of derivative liabilities   (1,384,423)   5,064,955    3,680,532    (6,449,378)   5,064,955    (1,384,423)
Loss on conversion   —      (250,640)   (250,640)   —      (250,640)   (250,640)
Other expense   (612,894)   611,629    (1,265)   (979,799)   617,545    (362,254)
                               
Total non-operating income (expense)   (2,286,594)   5,618,114    3,331,520    (7,909,709)   5,623,114    (2,286,595)
                               
Net income (loss)   (4,278,814)   7,067,686    2,788,872    (11,348,323)   7,069,509    (4,278,814)
                               
Basic net income (loss) per share   (0.02)   0.03    0.01    (0.05)   0.03    (0.02)
Diluted net income (loss) per share   (0.02)   0.03    0.01    (0.05)   0.03    (0.02)
                               
Basic weighted average common shares outstanding   247,395,774    —      247,395,774    237,925,753    —      237,925,753 
Diluted weighted average common shares outstanding *   247,395,774    —      247,395,774    237,925,753    —      237,925,753 

 

   For the Nine Months Ended March 31, 2018
   (Original)  (Adjustment)  (Restated)
Cash flows from operating activities:               
Net loss   (11,348,323)   7,069,509    (4,278,814)
Adjustments to reconcile net loss to cash flows from operating activities:   125,642    —      125,642 
Initial valuation of debt discount               
Loss on settlement   —      250,460    250,460 
Amortization of debt discount   314,677    49,986    364,663 
Stock based compensation   926,754    (137,525)   789,229 
Change in fair value of derivative liability   9,578,061    (8,193,638)   1,384,423 
Depreciation and amortization   —      85,807    85,807 
                
Changes in assets and liabilities:               
Accounts receivable   (239,302)   —      (239,302)
Inventory   100,447    —      100,447 
Other assets   (374,664)   —      (374,664)
Bank overdraft   13,260    —      13,260 
Accounts payable and accrued liabilities   (194,809)   —      (194,809)
Customer deposits   66,713    —      66,713 
Unearned revenue   (11,970)   —      (11,970)
Accrued interest and Other payables   3,317    50,000    53,317 
                
Net cash used in operating activities   954,390    (2,819,987)   (1,865,597)
                
Cash flows from investing activities:               
Acquisition of intangible assets   (13,999)   —      (13,999)
Acquisition of property and equipment   (133,132)   —      (133,132)
                
Net cash used in investing activities   (147,131)   —      (147,131)
                
Cash flows from financing activities:               
Proceeds from shares to be issued   361,478    961,207    1,322,685 
Proceeds from convertible notes   702,653    (50,000)   652,653 
Repayment of notes payable   —      —      —   
Payment to Note payable-related parties   (22,666)   —      (22,666)
Proceeds from loans   30,342    —      30,342 
Repayment of loan payable-related parties   (158,617)   —      (158,617)
Repayment of loans   —      —      —   
Proceeds from advance share issuance   95,094    —      95,094 
Loan receivable   —      —      —   
                
Net cash provided by financing activities   1,008,284    911,207    1,919,491 
                
Net increase (decrease) in cash   (93,237)   —      (93,237)
                
Cash paid during the period for:               
Cash, beginning of period   101,880    —      101,880 
Cash, end of period   8,643    —      8,643 
                
Interest   —      —      —   
Income taxes   —      —      —   
Supplemental disclosure of non-cash financing activities Debts settled through shares issuance   993,250    —      993,250